Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Monday.

According to Zacks, “In last three months, shares of Acadia Healthcare have lost value. But the company suffers from high debt, escalating interest expenses. Acadia Healthcare’s growing international operations expose it to foreign currency rate fluctuations. Its balance sheet is highly leveraged. The company's long-term debt has increased consistently for the past many years, leading to an increase in interest expense. Substantial integration risks associated with its frequent acquisitions are major headwinds.”

ACHC has been the topic of several other reports. Mizuho lifted their price target on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 28th. BidaskClub upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Deutsche Bank AG upped their price objective on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a report on Monday, July 31st. Craig Hallum restated a “buy” rating and issued a $65.00 price objective (up previously from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, William Blair started coverage on Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating for the company. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $56.55.

Shares of Acadia Healthcare (ACHC) opened at 47.50 on Monday. The company has a 50 day moving average of $46.99 and a 200 day moving average of $46.21. The stock has a market capitalization of $4.17 billion, a price-to-earnings ratio of 521.98 and a beta of 1.07. Acadia Healthcare has a 52-week low of $32.54 and a 52-week high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The firm had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 earnings per share. Analysts predict that Acadia Healthcare will post $2.45 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Rating Lowered to Sell at Zacks Investment Research” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/acadia-healthcare-company-inc-achc-rating-lowered-to-sell-at-zacks-investment-research/1606491.html.

In other Acadia Healthcare news, insider Scott Schwieger sold 2,891 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the sale, the insider now directly owns 8,841 shares of the company’s stock, valued at $467,246.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, President Brent Turner sold 206,252 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The disclosure for this sale can be found here. Insiders sold a total of 3,085,693 shares of company stock worth $157,729,099 in the last three months. 11.10% of the stock is currently owned by company insiders.

Institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in shares of Acadia Healthcare by 65.6% during the second quarter. BlackRock Inc. now owns 8,523,077 shares of the company’s stock valued at $420,871,000 after acquiring an additional 3,377,291 shares during the period. Vanguard Group Inc. lifted its position in shares of Acadia Healthcare by 8.9% in the 2nd quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock valued at $308,849,000 after acquiring an additional 511,299 shares in the last quarter. Aristotle Capital Management LLC purchased a new stake in shares of Acadia Healthcare in the 1st quarter valued at approximately $140,071,000. FMR LLC lifted its position in shares of Acadia Healthcare by 26.4% in the 2nd quarter. FMR LLC now owns 2,775,451 shares of the company’s stock valued at $137,052,000 after acquiring an additional 580,449 shares in the last quarter. Finally, Frontier Capital Management Co. LLC lifted its position in shares of Acadia Healthcare by 11.5% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 2,328,063 shares of the company’s stock valued at $114,960,000 after acquiring an additional 240,975 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.